X. Le , L. Hendriks , A. Morabito , L. Bonanno , I. Okamoto , J.W. Goldman , H.A. Yu , O.T. Brustugun , T.O. Halvorsen , Y.J. Kim , K. Marrone , B.C. Cho , J.W. Riess , A.J. De Langen , Z. Piotrowska , H. Ambrose , P. Smith , J.M. Lehman , P.G. Fraenkel , S.B. Goldberg
{"title":"10:奥西替尼(osi) + datoopotamab deruxtecan (Dato-DXd)用于egfr突变(EGFRm)晚期NSCLC (aNSCLC)患者(pts),其疾病在一线(1L) osi ORCHARD进展","authors":"X. Le , L. Hendriks , A. Morabito , L. Bonanno , I. Okamoto , J.W. Goldman , H.A. Yu , O.T. Brustugun , T.O. Halvorsen , Y.J. Kim , K. Marrone , B.C. Cho , J.W. Riess , A.J. De Langen , Z. Piotrowska , H. Ambrose , P. Smith , J.M. Lehman , P.G. Fraenkel , S.B. Goldberg","doi":"10.1016/S1556-0864(25)00196-0","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Pages S2-S4"},"PeriodicalIF":21.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"1O: Osimertinib (osi) + datopotamab deruxtecan (Dato-DXd) in patients (pts) with EGFR-mutated (EGFRm) advanced NSCLC (aNSCLC) whose disease progressed on first-line (1L) osi: ORCHARD\",\"authors\":\"X. Le , L. Hendriks , A. Morabito , L. Bonanno , I. Okamoto , J.W. Goldman , H.A. Yu , O.T. Brustugun , T.O. Halvorsen , Y.J. Kim , K. Marrone , B.C. Cho , J.W. Riess , A.J. De Langen , Z. Piotrowska , H. Ambrose , P. Smith , J.M. Lehman , P.G. Fraenkel , S.B. Goldberg\",\"doi\":\"10.1016/S1556-0864(25)00196-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17515,\"journal\":{\"name\":\"Journal of Thoracic Oncology\",\"volume\":\"20 3\",\"pages\":\"Pages S2-S4\"},\"PeriodicalIF\":21.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Thoracic Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1556086425001960\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thoracic Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1556086425001960","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer,is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies.The readship includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology.